VivoSim Labs, INC.VIVS

NasdaqHealthcareBiological Products, (No Diagnostic Substances)
Price (close)
$0.23
Market cap
$3.3M
P/E
—
Revenue (TTM)
$112,000
Net income
-$12.3M
Dividend yield
—
1-year total return
-93.5%
Net margin
-11016.1%
Revenue growth
-21.1%
Debt / equity
—

What VivoSim Labs, INC. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202120222023202420252026
Revenue$0$1.5M$370,000$109,000$144,000$131,000
Net income-$16.8M-$11.4M-$17.3M-$14.7M-$2.5M-$13.8M
Free cash flow-$13.7M-$8.9M-$12.8M-$14.7M-$9.5M-$10.8M

More on VIVS.

Figures from VivoSim Labs, INC.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.